169 related articles for article (PubMed ID: 1971398)
1. Donor HIV-1 p24 antigenaemia and course of infection in recipients Transfusion Safety Study Group.
Busch MP; Donegan E; Stuart M; Mosley JW
Lancet; 1990 Jun; 335(8701):1342. PubMed ID: 1971398
[No Abstract] [Full Text] [Related]
2. HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.
Mulder JW; Krijnen P; Goudsmit J; Schattenkerk JK; Reiss P; Lange JM
Genitourin Med; 1990 Jun; 66(3):138-41. PubMed ID: 2115018
[TBL] [Abstract][Full Text] [Related]
3. Transient elevation of serum HIV antigen levels associated with intercurrent infection.
Claydon EJ; Bennett J; Gor D; Forster SM
AIDS; 1991 Jan; 5(1):113-4. PubMed ID: 1905552
[No Abstract] [Full Text] [Related]
4. Prevalence of HIV-1 p24 antigenemia in African and North American populations and correlation with clinical status.
Brown C; Kline R; Atibu L; Francis H; Ryder R; Quinn TC
AIDS; 1991 Jan; 5(1):89-92. PubMed ID: 1905553
[TBL] [Abstract][Full Text] [Related]
5. CD4 lymphocyte counts and serum p24 antigen of no diagnostic value in monitoring HIV-infected patients with pulmonary symptoms.
Orholm M; Nielsen TL; Nielsen JO; Lundgren JD
AIDS; 1990 Feb; 4(2):163-6. PubMed ID: 1970256
[TBL] [Abstract][Full Text] [Related]
6. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
[TBL] [Abstract][Full Text] [Related]
7. Sensitive one-step enzyme immunoassay for HIV-1 p24 antigen in human blood specimens and cell culture supernatants.
Kontio S
J Immunol Methods; 1991 Jun; 139(2):257-63. PubMed ID: 1904466
[TBL] [Abstract][Full Text] [Related]
8. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
[TBL] [Abstract][Full Text] [Related]
10. Serological markers as prognostic criteria for the course of HIV infection.
Kleinschmidt A; Matuschke A; Goebel FD; Erfle V; Hehlmann R
Infection; 1991; 19 Suppl 2():S89-92. PubMed ID: 1901833
[TBL] [Abstract][Full Text] [Related]
11. Zidovudine treatment of an infant with congenital human immunodeficiency virus infection.
Millard DD; Chadwick EG; Yogev R; Modlin JF
Pediatr Infect Dis J; 1990 Dec; 9(12):929-31. PubMed ID: 2126136
[No Abstract] [Full Text] [Related]
12. Quantitation of human immunodeficiency virus in vertically infected infants and children.
Alimenti A; Luzuriaga K; Stechenberg B; Sullivan JL
J Pediatr; 1991 Aug; 119(2):225-9. PubMed ID: 1677684
[TBL] [Abstract][Full Text] [Related]
13. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
[TBL] [Abstract][Full Text] [Related]
15. Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects.
Mulder JW; Lange JM; de Wolf F; Houweling JT; Bakker M; Coutinho RA; Goudsmit J
Neth J Med; 1990 Aug; 37(1-2):4-10. PubMed ID: 2120599
[TBL] [Abstract][Full Text] [Related]
16. Surrogate markers for AIDS treatment.
Jacobson M
Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013
[No Abstract] [Full Text] [Related]
17. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals.
Nishanian P; Huskins KR; Stehn S; Detels R; Fahey JL
J Infect Dis; 1990 Jul; 162(1):21-8. PubMed ID: 2113075
[TBL] [Abstract][Full Text] [Related]
18. Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short-term outcome of neonatal infection. Results of a prospective cohort study.
Andiman WA; Simpson BJ; Olson B; Dember L; Silva TJ; Miller G
Am J Dis Child; 1990 Jul; 144(7):758-66. PubMed ID: 2113349
[TBL] [Abstract][Full Text] [Related]
19. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Merigan TC; Skowron G
Am J Med; 1990 May; 88(5B):11S-15S. PubMed ID: 2159703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]